e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Treatment of IPF
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC Abstract – Inhibition of oxygen sensing HIF prolyl hydroxylases in humans presents a novel therapeutic target for the fibrotic lung
Benjamin Scally (Edinburgh, United Kingdom), Benjamin Scally, Andreas Alber, Sarah Howie, Nik Hirani
Source:
International Congress 2015 – Treatment of IPF
Session:
Treatment of IPF
Session type:
Oral Presentation
Number:
4496
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Benjamin Scally (Edinburgh, United Kingdom), Benjamin Scally, Andreas Alber, Sarah Howie, Nik Hirani. LSC Abstract – Inhibition of oxygen sensing HIF prolyl hydroxylases in humans presents a novel therapeutic target for the fibrotic lung. Eur Respir J 2015; 46: Suppl. 59, 4496
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Imaging of the HIF pathway – clues on oxygen sensing
Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease
Year: 2006
HIF pathway activation is a core regulator of collagen structure-function in lung fibrosis
Source: Virtual Congress 2020 – Lung epithelial development and repair in three-dimensions
Year: 2020
Targeting intermittent hypoxia downstream pathways for biomarker discovery and new treatment perspectives in cutaneous melanoma
Source: Eur Respir J, 53 (2) 1802444; 10.1183/13993003.02444-2018
Year: 2019
Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 804s
Year: 2006
Role of the JAK/STAT pathway in activation of the xanthine dehydrogenase/oxidase in lung microvascular endothelial cells exposure to hypoxia
Source: Eur Respir J 2007; 30: Suppl. 51, 145s
Year: 2007
Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Upregulated HIF (hypoxia inducible factor)-1 DNA binding activity to VEGF-a promoter mediates oedema formation in donor lung grafts
Source: Eur Respir J 2003; 22: Suppl. 45, 7s
Year: 2003
Targeting AMPK and the Nrf2/HO-1 axis: a promising therapeutic strategy in acute lung injury
Source: Eur Respir J, 58 (6) 2102238; 10.1183/13993003.02238-2021
Year: 2021
A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels
Source: Eur Respir J, 51 (4) 1702229; 10.1183/13993003.02229-2017
Year: 2018
Targeting metabolic reprogramming as a novel anti-fibrotic strategy
Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease
Year: 2019
Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017
SH2 domain-containing Phosphatase-(SHP)-2 blunts fibrotic responses through regulation of fibroblast mitochondrial metabolism and autophagy
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
Sirtuins inhibition modulates endotoxin-induced lung inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Late Breaking Abstract - Role of HIF2a oxygen sensing pathway in bronchial epithelium biology
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
Glutathione redox regulates TGF-β-induced Smad activation and fibrogenic effect in human airway
Source: Eur Respir J 2007; 30: Suppl. 51, 496s
Year: 2007
Gene regulatory roles for lysyl oxidases in the context of BPD
Source: International Congress 2017 – Molecular biology of normal and abnormal lung development
Year: 2017
Role of lysyl oxidases in pathogenesis of pulmonary emphysema
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept